Study location
| | | | |
United States
|
6
|
75%
|
0
| |
Europe
|
1
|
13%
|
1
|
33%
|
Japan
|
1
|
13%
|
2
|
67%
|
Gender
| | | | |
Women
|
3
|
38%
|
0
| |
Men
|
2
|
25%
|
0
| |
Both men and women
|
3
|
38%
|
3
|
100
|
Case of T2D
| | | | |
1 to 4,999
|
2
|
25%
|
1
|
33%
|
500 to 4,999
|
4
|
50%
|
2
|
67%
|
5,000+
|
2
|
25%
|
0
| |
Duration of follow-up
| | | | |
<10 years
|
4
|
50%
|
0
| |
10 to 14 years
|
1
|
13%
|
3
|
100%
|
15+ years
|
3
|
38%
|
0
| |
Mean baseline body mass index (kg/m2)
| | | | |
<24
|
1
|
13%
|
2
|
67%
|
24 to 26
|
4
|
50%
|
0
| |
>26
|
3
|
38%
|
1
|
33%
|
Number/timing of beverage assessment
| | | | |
Once at baseline (study length range from 7 to 16 years)
|
4
|
50%
|
3
|
100%
|
Twice (6-year interval)
|
1
|
13%
|
0
| |
Every 4 years
|
3
|
38%
|
0
| |
Proportion of study participants reporting ≥ serving/day
| | | | |
10% or fewer or low consumption
|
2
|
25%
|
3
|
100%
|
Between 11 and 15%
|
3
|
38%
|
0
| |
More than 15%
|
2
|
25%
|
0
| |
Not reported
|
1
|
13%
|
0
| |
Method of type 2 diabetes (T2D) diagnosis
| | | | |
Self report with validation
|
4
|
50%
|
2
|
67%
|
Direct measurement/medical records
|
4
|
50%
|
1
|
33%
|
Operation of study variable in multivariable models: highest versus lowest category of consumption
|
Highest consumption category:
| | | | |
2+ drinks or cups/dayARIC,BWHS
|
2
|
25%
|
0
|
33%
|
1+ glasses or servings/day
|
6
|
75%
|
1
|
67%
|
<1 serving/day
|
0
| |
2
| |
Lowest consumption category:
| | | | |
Never
|
2
|
25%
|
1
|
33%
|
never or rarely
|
5
|
63%
|
2
|
67%
|
<1 cup/dayARIC
|
1
|
13%
|
0
| |
Characterization of multivariable models
|
Range
|
Median
|
Range
|
Median
|
No multivariable models presented
|
1 to 8
|
4
|
2 to 4
|
3
|
Maximum number of co-variables in multivariable modelsa
|
9 to 17
|
14
|
14 to 17
|
15
|
Maximum% change in SSB-T2D risk from age-adjusted estimate
|
46 to 95%
|
61%
|
2 to 26%
|
18%
|